iSN04 serves as an anti-nucleolin aptamer that inhibits proliferation and induces differentiation not only of myoblasts but also of rhabdomyosarcoma, a soft tissue tumor of the striated muscle [10]. Here, NUCLEOLIN is linked to soft tissue neoplasm.